EGFR and lung carcinoma: Moreover, CAFs have also been shown to promote resistance in lung cancer cells to clinical standard therapies, such as chemotherapy,10, 11 epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs)12, 13, 14, 15 or immunotherapy.16, 17, 18